Sigilon Therapeutics Inc. (SGTX) News

Sigilon Therapeutics Inc. (SGTX): $22.47

0.59 (-2.56%)

POWR Rating

Component Grades








Add SGTX to Watchlist
Sign Up

Industry: Biotech




#164 of 458

in industry

Filter SGTX News Items

SGTX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest SGTX News From Around the Web

Below are the latest news stories about SIGILON THERAPEUTICS INC that investors may wish to consider to help them evaluate SGTX as an investment opportunity.

Biotech Stock Roundup: BMRN's Gene Therapy Gets Approval, SGTX Up on Buyout by LLY

Regulatory and acquisition updates from BioMarin (BMRN) and Sigilon (SGTX) are in focus in the biotech sector.

Yahoo | July 6, 2023

Sigilon (SGTX) Skyrockets 441% on Buyout Offer From Eli Lilly

Eli Lilly (LLY) is set to acquire Sigilon (SGTX) for $14.92 per share, in cash, along with a contingent value right of $111.64 per share.

Yahoo | June 30, 2023

Why Is Cormedix (CRMD) Stock Down 23% Today?

Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares.

William White on InvestorPlace | June 29, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

William White on InvestorPlace | June 29, 2023

Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?

BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data.

William White on InvestorPlace | June 29, 2023

Why Is Eco Wave Power Global (WAVE) Stock Up 58% Today?

Eco Wave Power Global (WAVE) stock is on the rise Thursday with heavy trading despite a lack of news concerning the wave energy company.

William White on InvestorPlace | June 29, 2023

Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?

Sigilon Therapeutics (SGTX) stock is rocketing higher on Thursday morning after Eli Lilly (LLY) agrees to acquire the company.

William White on InvestorPlace | June 29, 2023

Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 400%

Eli Lilly said Thursday it will buy its diabetes treatment partner, Sigilon Therapeutics, and the biotech stock skyrocketed.

Yahoo | June 29, 2023

Eli Lilly to Acquire Sigilon Therapeutics

Eli Lilly (LLY) shares rose more than 1% on Thursday after announcing it will acquire Sigilon Therapeutics (SGTX) in an all-cash deal worth up to $309.6 million. Eli Lilly will pay $14.92 per share or $34.6 million, along with $111.64 per share to shareholders if the company achieves specified regulatory and developmental goals. According to the terms of the agreement, total compensation could jump to $125.56 per share or $309.6 million, if certain development, research, and regulatory goals are met.

Yahoo | June 29, 2023

Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On

Sigilon Therapeutics Inc (NASDAQ: SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE: LLY) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of approximately $34.6 million). Sigilon is also entitled to one non-tradeable contingent value right ("CVR") per share to receive up to an additional $111.64 per share in cash, for a total potential consideration of up to $126.56 per share in cash without interest (an aggregate of up to approximately $309.

Yahoo | June 29, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!